Literature DB >> 11469450

Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis.

T Pufe1, W Petersen, B Tillmann, R Mentlein.   

Abstract

OBJECTIVE: To determine the expression of the angiogenic peptide vascular endothelial growth factor (VEGF, also known as vascular permeability factor, VPF) in the synovium of patients with rheumatoid arthritis (RA).
METHODS: Expression of VEGF protein from the synovial tissue of 10 patients with RA was monitored by ELISA and visualized by immunocytochemistry, and by double-staining with the VEGFR-1/flt-1. VEGF mRNA and its splice variants were determined by reverse transcriptase polymerase chain reaction (RT-PCR).
RESULTS: VEGF protein was strongly increased in rheumatoid synovium and localized at the synovial surface, whereas the VEGF receptor flt-1 (VEGFR-1) was visualized on microvessels in close vicinity. In synovial tissues from all 10 patients with RA, VEGF121 and VEGF165 were identified at the mRNA level as the only VEGF splice forms expressed.
CONCLUSION: Since VEGF165 and VEGF121 are differently diffusible due to their opposite heparan sulfate-binding properties, they act at different distances. The presence of VEGF121 may explain induction of the VEGFR-1 on infiltrating blood vessels near the synovial surface.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11469450

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

Review 1.  Tyrosine kinases as targets for the treatment of rheumatoid arthritis.

Authors:  Christina D'Aura Swanson; Ricardo T Paniagua; Tamsin M Lindstrom; William H Robinson
Journal:  Nat Rev Rheumatol       Date:  2009-06       Impact factor: 20.543

2.  Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis.

Authors:  Toshihiro Nagai; Masato Sato; Miyuki Kobayashi; Munetaka Yokoyama; Yoshiki Tani; Joji Mochida
Journal:  Arthritis Res Ther       Date:  2014-09-18       Impact factor: 5.156

3.  Investigation of chondrocyte hypertrophy and cartilage calcification in a full-depth articular cartilage explants model.

Authors:  Pingping Chen-An; Kim Vietz Andreassen; Kim Henriksen; Morten Asser Karsdal; Anne-Christine Bay-Jensen
Journal:  Rheumatol Int       Date:  2012-03-28       Impact factor: 2.631

4.  Gliostatin/thymidine phosphorylase-regulated vascular endothelial growth-factor production in human fibroblast-like synoviocytes.

Authors:  Tomohiro Tanikawa; Yuko Waguri-Nagaya; Takuma Kusabe; Mineyoshi Aoyama; Kiyofumi Asai; Takanobu Otsuka
Journal:  Rheumatol Int       Date:  2006-11-14       Impact factor: 2.631

Review 5.  The essential anti-angiogenic strategies in cartilage engineering and osteoarthritic cartilage repair.

Authors:  Song Chen; Yixuan Amy Pei; Ming Pei
Journal:  Cell Mol Life Sci       Date:  2022-01-14       Impact factor: 9.261

6.  Expression of VEGF121 and VEGF165 in hypertrophic chondrocytes of the human growth plate and epiphyseal cartilage.

Authors:  Wolf Petersen; Michael Tsokos; Thomas Pufe
Journal:  J Anat       Date:  2002-08       Impact factor: 2.610

7.  Immunolocalization of vascular endothelial growth factor in rat condylar cartilage during postnatal development.

Authors:  Junko Aoyama; Eiji Tanaka; Mutsumi Miyauchi; Takashi Takata; Koichi Hanaoka; Yukiko Hattori; Akiko Sasaki; Mineo Watanabe; Kazuo Tanne
Journal:  Histochem Cell Biol       Date:  2004-07-01       Impact factor: 4.304

8.  Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor.

Authors:  Thomas Pufe; Angelika Lemke; Bodo Kurz; Wolf Petersen; Bernhard Tillmann; Alan J Grodzinsky; Rolf Mentlein
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

Review 9.  VEGF and imaging of vessels in rheumatoid arthritis.

Authors:  Peter C Taylor
Journal:  Arthritis Res       Date:  2002-05-09

Review 10.  Angiogenesis in rheumatoid arthritis.

Authors:  Ewa M Paleolog
Journal:  Arthritis Res       Date:  2002-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.